Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Liquid Biopsies and Minimally-Invasive Diagnostics 2016

James Han's Biography



James Han, Director, Bioinformatics, Genomic Health

James has over 10 years of experience developing data analysis methods for high-volume commercial and scientific research applications. He is currently the Director of Bioinformatics at Genomic Health where he builds data analysis algorithms for cancer diagnostics. Prior to his work in diagnostics, James developed sequence analysis algorithms for bioenergy research at the Joint Genome Institute.

James Han Image

Liquid Biopsies in the Management of Cancer

Friday, 30 September 2016 at 09:00

Add to Calendar ▼2016-09-30 09:00:002016-09-30 10:00:00Europe/LondonLiquid Biopsies in the Management of CancerLiquid Biopsies and Minimally-Invasive Diagnostics 2016 in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com

Liquid biopsies can be used to monitor tumor dynamics including recurrence or to profile individual genetic and genomic markers that are informative of treatment options.  Together, these complementary approaches provide precision solutions to help manage disease along the patient cancer journey.  These also call for different development, analytical and clinical validation strategies, as well as demonstration of clinical utility.  As these assays become more routine and move toward standard of care, it will be important to provide accurate and relevant test performance information.  I will discuss the role of standards to ensure quality and allow appropriate interpretation of test results.


Add to Calendar ▼2016-09-29 00:00:002016-09-30 00:00:00Europe/LondonLiquid Biopsies and Minimally-Invasive Diagnostics 2016Liquid Biopsies and Minimally-Invasive Diagnostics 2016 in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com